Bioxcel therapeutics to report fourth quarter and full year 2021 financial results on march 10, 2022

New haven, conn., feb. 24, 2022 (globe newswire) -- bioxcel therapeutics, inc. (nasdaq: btai), a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced that it will release its fourth quarter and full year 2021 financial results on thursday, march 10, 2022 before the open of the u.s. financial markets. bioxcel therapeutics' management team will also host a conference call and webcast at 8:30 am et to discuss the company's financial results and to provide a general business update.
BTAI Ratings Summary
BTAI Quant Ranking